The 85 rating InvestorsObserver gives to Neon Therapeutics Inc (NTGN) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 99 percent of stocks in the Biotechnology industry, NTGNs 85 overall rating means the stock scores better than 85 percent of all stocks.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 85 means the stock is more attractive than 85 percent of stocks.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

Neon Therapeutics Inc (NTGN) stock has gained 4.58% while the S&P 500 has fallen -4.94% as of 9:51 AM on Wednesday, Mar 18. NTGN is higher by $0.12 from the previous closing price of $2.62 on volume of 267,999 shares. Over the past year the S&P 500 has fallen -15.12% while NTGN has fallen -53.56%. NTGN lost -$2.86 per share the over the last 12 months.

To see InvestorsObserver's Sentiment Score for Neon Therapeutics Inc click here.

The rest is here:
Industry Breakdown: Where Does Neon Therapeutics Inc (NTGN) Stock Fall in the Biotechnology Field? - InvestorsObserver